Production (Stage)
Guardant Health, Inc.
GH
$38.00
$0.952.56%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -416.55M | -436.37M | -512.41M | -490.76M | -460.90M |
| Total Depreciation and Amortization | 41.91M | 42.39M | 42.80M | 43.24M | 43.25M |
| Total Amortization of Deferred Charges | 1.94M | 1.94M | 1.93M | 1.93M | 1.93M |
| Total Other Non-Cash Items | 192.50M | 213.05M | 207.46M | 154.83M | 91.40M |
| Change in Net Operating Assets | -92.07M | -60.86M | 6.14M | 9.95M | 43.50M |
| Cash from Operations | -272.26M | -239.86M | -254.07M | -280.81M | -280.82M |
| Capital Expenditure | -32.61M | -35.09M | -20.29M | -18.46M | -19.90M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 46.10M | -226.22M | 411.90M | 965.60M | 730.99M |
| Cash from Investing | 13.49M | -261.31M | 391.62M | 947.14M | 711.09M |
| Total Debt Issued | 5.03M | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 15.39M | 14.84M | 104.00M | 104.05M | 503.73M |
| Repurchase of Common Stock | -74.64M | -15.68M | -10.74M | -10.87M | -11.75M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -12.55M | -153.00K | -747.00K | 6.02M | -14.83M |
| Cash from Financing | -66.77M | -996.00K | 92.51M | 99.20M | 477.16M |
| Foreign Exchange rate Adjustments | 141.00K | -1.77M | 955.00K | -1.47M | -1.89M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -325.40M | -503.93M | 231.01M | 764.07M | 905.54M |